Novavax, Inc.
Короткая

NVAX Short

Novavax will issue a statement ahead of their upcoming earnings in a couple of weeks that they have scrapped the plans for a Covid-19 vaccine and now instead they are working on a Covid-flu combo for the next year . The insiders and the main hedge fund manager Peter Kolchinsky have already shorted the stock last week . I fully expect It will be anywhere between $40-$77 in three weeks time . Good luck !
Beyond Technical AnalysisFundamental AnalysisnovavaxNVAXnvaxlongTrend Analysis

Отказ от ответственности